Gilde Healthcare
Overview
Gilde Healthcare is a specialized healthcare investment firm that manages venture & growth and private equity funds focused on innovative healthtech, therapeutics, and lower mid-market healthcare companies in Europe and North America.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Karius | May 2024 | Series C | Lead |
| SpyGlass Pharma | Feb 2026 | IPO | Co-investor |
| Shoulder Innovations | Mar 2025 | Series E | Co-investor |
| MicroTransponder | Mar 2025 | Series F | Co-investor |
| Withings | Jul 2020 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
David de Graaf
Founding Partner - Climate Solutions Fund
Edwin de Graaf
Managing Partner
Jasper van Gorp
Managing Partner
Marc Perret
Managing Partner
Joep Muijrers
General Partner
Boyd Rutten
Partner
Michael Tutera
Operational Partner
Mika Nishimura
Operational Partner
Paul Parren
Operational Partner
Robert Stein
Partner
Stefan Luzi
Partner
Henry Zubaida
Investment Director
Susana Amorim Lopes
Investment Director
Edward Hanlon
Investment Manager - Venture And Growth
Joep Heldens
Investment Manager
Josephine Bogaerts
Investment Manager Private Equity
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Gilde Healthcare based?
Gilde Healthcare is headquartered in Utrecht, Netherlands.
When was Gilde Healthcare founded?
Gilde Healthcare was founded in 1982.
How many portfolio companies does Gilde Healthcare have?
Gilde Healthcare has 47 portfolio companies in Caplight's dataset.
What are some companies in Gilde Healthcare's portfolio?
Portfolio companies visible on Caplight include Karius, SpyGlass Pharma, Shoulder Innovations, MicroTransponder, Withings.
What was Gilde Healthcare's most recent investment shown here?
Gilde Healthcare's most recent investment in this portfolio sample was in SpyGlass Pharma in 2026.
What sectors does Gilde Healthcare focus on?
Gilde Healthcare focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Gilde Healthcare focus on?
Gilde Healthcare typically invests at the MultiStage stage.
What is Gilde Healthcare's AUM?
Gilde Healthcare's assets under management are estimated between $1.0B and $10.0B.